Trials / Completed
CompletedNCT01842009
Single-arm, Open-label, Phase II Trial of HD-tDCS in Fibromyalgia Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Spaulding Rehabilitation Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the mean number of stimulation (high definition-transcranial direct current stimulation) sessions (up to 26) needed to achieve a clinical response with this response defined as a 50% decrease in Visual Analog Scale (VAS) for pain. These data will be important in defining the optimal number of sessions for future fibromyalgia subjects in Phase III trials.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | High Definition transcranial Direct Current Stimulation |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2014-07-01
- Completion
- 2016-06-07
- First posted
- 2013-04-29
- Last updated
- 2020-04-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01842009. Inclusion in this directory is not an endorsement.